QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report.

QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report. Turk Psikiyatri Derg. 2018;29(1):67-68 Authors: Gıll JS, Sulaıman AH Abstract Asenapine is one of the newer atypical antipsychotics on the market. It is a sublingually administered drug that is indicated for the treatment of both schizophrenia and bipolar disorder, and is considered to be safe and well tolerated. Herein, we report a 71-year-old female with a history of bipolar disorder who had ventricular trigemini and experienced a large increase in her QTc interval after starting treatment with asenapine. These changes ceased following withdrawal of asenapine. In this case report, we discuss the importance of cardiac monitoring when switching antipsychotics, even to those that are considered to have low cardiac risk. PMID: 29730876 [PubMed - in process]
Source: Turkish Journal of Psychiatry - Category: Psychiatry Authors: Tags: Turk Psikiyatri Derg Source Type: research